» Articles » PMID: 15945534

Usual Interstitial Pneumonia Complicating Dyskeratosis Congenita

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 2005 Jun 11
PMID 15945534
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Dyskeratosis congenita (DC) is a rare disorder characterized by skin hyperpigmentation, nail dystrophy, and leukoplakia of mucous membranes. Pulmonary complications occur in approximately 20% of patients, although the specific histopathologic features, the temporal relationship between the diagnosis of DC and the development of pulmonary fibrosis, and the response to specific treatment are largely undefined. We describe 2 patients with DC who developed usual interstitial pneumonia. Pulmonary fibrosis developed 18 and 38 years after the original manifestations of DC. Both patients died of respiratory failure, 4 and 6 months after lung biopsy. Pulmonary fibrosis in patients with DC may be linked to underlying abnormalities of fibroblast function.

Citing Articles

Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.

Reccardini N, Chernovsky M, Salton F, Confalonieri P, Mondini L, Barbieri M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065780 PMC: 11280355. DOI: 10.3390/ph17070930.


Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.

Wang P, Xu Z BMC Pulm Med. 2021; 21(1):279.

PMID: 34479523 PMC: 8418029. DOI: 10.1186/s12890-021-01645-w.


Diverse Pathological Findings of Interstitial Lung Disease in a Patient with Dyskeratosis Congenita.

Otoshi R, Baba T, Shintani R, Kitamura H, Yamaguchi Y, Hamanoue H Intern Med. 2020; 60(8):1257-1263.

PMID: 33191321 PMC: 8112977. DOI: 10.2169/internalmedicine.5143-20.


Familial Interstitial Lung Disease.

Kropski J Semin Respir Crit Care Med. 2020; 41(2):229-237.

PMID: 32279293 PMC: 7272214. DOI: 10.1055/s-0040-1708054.


Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Zaman T, Lee J Curr Pulmonol Rep. 2019; 7(4):118-125.

PMID: 31588408 PMC: 6777743. DOI: 10.1007/s13665-018-0210-7.